Cargando…

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer

To develop and externally validate a prostate health index (PHI)-based nomogram for predicting the presence of prostate cancer (PCa) at biopsy in Chinese men with prostate-specific antigen 4–10 ng/mL and normal digital rectal examination (DRE). 347 men were recruited from two hospitals between 2012...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yao, Han, Cheng-Tao, Zhang, Gui-Ming, Liu, Fang, Ding, Qiang, Xu, Jian-Feng, Vidal, Adriana C., Freedland, Stephen J., Ng, Chi-Fai, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607975/ https://www.ncbi.nlm.nih.gov/pubmed/26471350 http://dx.doi.org/10.1038/srep15341

Ejemplares similares

Effect of Body mass index on the performance characteristics of PSA-related markers to detect prostate cancer
por: Zhu, Yao, et al.
Publicado: (2016)

External validation of extended prostate biopsy nomogram
por: Hrbáček, Jan, et al.
Publicado: (2015)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort
por: Tang, Bo, et al.
Publicado: (2017)

External Validation of an Artificial Neural Network and Two Nomograms for Prostate Cancer Detection
por: Ecke, Thorsten H., et al.
Publicado: (2012)

External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
por: Yang, Yun-Jie, et al.
Publicado: (2018)

An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy
por: Gabriele, Domenico, et al.
Publicado: (2021)

Re: Commentary on “The association between sexual function and prostate cancer risk in US veterans”
por: Vidal, Adriana C, et al.
Publicado: (2018)

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
por: Johnston, Ashley W., et al.
Publicado: (2020)

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer
por: Zhang, Tingwei, et al.
Publicado: (2023)

Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study
por: Zhou, Zhong-Han, et al.
Publicado: (2020)

Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China
por: Huang, Da, et al.
Publicado: (2020)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
por: Yu, Guo-Peng, et al.
Publicado: (2016)

External Validation of the Briganti Nomogram to Predict Lymph Node Invasion in Prostate Cancer—Setting a New Threshold Value
por: Małkiewicz, Bartosz, et al.
Publicado: (2021)

External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery
por: Zhu, Yao, et al.
Publicado: (2014)

Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE
por: Fischer, Sean, et al.
Publicado: (2016)

Development and validation of a nomogram for predicting early stress urinary incontinence following endoscopic enucleation of the prostate
por: Li, Xuanhao, et al.
Publicado: (2021)

Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer
por: Moghanaki, Drew, et al.
Publicado: (2019)

Validation of an MRI-based prostate cancer prebiopsy Gleason score predictive nomogram
por: Lee, Adrianna Jiaying, et al.
Publicado: (2022)

Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer
por: Feng, Fu, et al.
Publicado: (2023)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk
por: Xiao, Jialin, et al.
Publicado: (2017)

Survival nomogram for medulloblastoma and multi-center external validation cohort
por: Li, Xiang, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for neuroendocrine prostate cancer, based on the SEER database
por: Chen, Siming, et al.
Publicado: (2023)

Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer
por: Imamoto, Takashi, et al.
Publicado: (2011)

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer
por: Lin, Guo-Wen, et al.
Publicado: (2015)

The association between sexual function and prostate cancer risk in US veterans
por: Zapata, Daniel F, et al.
Publicado: (2017)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
por: Kim, Jae Yeon, et al.
Publicado: (2023)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
por: Chiu, Peter Ka-Fung, et al.
Publicado: (2016)

A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients
por: Wang, Jin-You, et al.
Publicado: (2014)

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2018)

External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2020)

Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men
por: Vidal, Adriana C., et al.
Publicado: (2019)

Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer
por: Chao, Hann‐Hsiang, et al.
Publicado: (2022)

Nutrition, dietary interventions and prostate cancer: the latest evidence
por: Lin, Pao-Hwa, et al.
Publicado: (2015)

Integration of magnetic resonance imaging into prostate cancer nomograms
por: Brinkley, Garrett J., et al.
Publicado: (2022)

Application Value of Radiomic Nomogram in the Differential Diagnosis of Prostate Cancer and Hyperplasia
por: Gui, Shaogao, et al.
Publicado: (2022)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
por: Thurtle, David R., et al.
Publicado: (2019)

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer
por: Nyberg, Tommy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdidnna2jrihgu6i3oi61uk6aa